Insider Transactions in Q1 2025 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
921
-4.78%
|
$2,763
$3.92 P/Share
|
|
Mar 03
2025
|
Thomas J Klima |
SELL
Open market or private sale
|
Direct |
500
-5.97%
|
$1,500
$3.92 P/Share
|
|
Mar 03
2025
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
584
-7.13%
|
$1,752
$3.92 P/Share
|
|
Feb 10
2025
|
Andrew Obenshain President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
763
+3.81%
|
-
|
|
Feb 03
2025
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
86
-0.46%
|
$602
$7.39 P/Share
|
|
Feb 03
2025
|
Joseph Vittiglio Chief Business & Legal Officer |
SELL
Open market or private sale
|
Direct |
238
-5.02%
|
$1,666
$7.39 P/Share
|
|
Feb 03
2025
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.78%
|
$448
$7.39 P/Share
|
|
Feb 03
2025
|
Thomas J Klima |
SELL
Open market or private sale
|
Direct |
122
-1.44%
|
$854
$7.39 P/Share
|
|
Jan 06
2025
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
140
-0.75%
|
$1,260
$9.24 P/Share
|
|
Jan 06
2025
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19
-0.23%
|
$171
$9.24 P/Share
|